6054-98-4
Chemical Structure
Olsalazine Disodium
- CAS No.: 6054-98-4
- Formula:C14H8N2Na2O6
- Molecular Weight:346.20
IUPAC Name: sodium (E)-5,5'-(diazene-1,2-diyl)bis(2-hydroxybenzoate)
InChIKey: ZJEFYLVGGFISGT-VRZXRVJBSA-L
SMILES: O=C(O[Na])C1=C(O)C=CC(/N=N/C2=CC(C(O[Na])=O)=C(O)C=C2)=C1
Biological Activity: Olsalazine Disodium is an orally active prodrug of 5-ASA (HY-15027). Olsalazine Disodium can inhibit cells proliferation and induce apoptosis. Olsalazine Disodium can reduce DAI and MPO activity and inhibit inflammatory cytokines levels. Olsalazine Disodium can be used for the researches of cancer, inflammation and metabolic disease, such as colorectal cancer, inflammatory bowel disease (IBD) and hyperuricemic[1][2][3][4].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Olsalazine Disodium | 99.85% | Olsalazine Disodium is an orally active prodrug of 5-ASA (HY-15027). Olsalazine Disodium can inhibit cells proliferation and induce apoptosis. Olsalazine Disodium can reduce DAI and MPO activity and inhibit inflammatory cytokines levels. Olsalazine Disodium can be used for the researches of cancer, inflammation and metabolic disease, such as colorectal cancer, inflammatory bowel disease (IBD) and hyperuricemic. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Olsalazine Disodium (Standard) | ≥98% | Olsalazine Disodium (Standard) is an orally active prodrug of 5-ASA (HY-15027). Olsalazine Disodium (Standard) can inhibit cells proliferation and induce apoptosis. Olsalazine Disodium (Standard) can reduce DAI and MPO activity and inhibit inflammatory cytokines levels. Olsalazine Disodium (Standard) can be used for the researches of cancer, inflammation and metabolic disease, such as colorectal cancer, inflammatory bowel disease (IBD) and hyperuricemic. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Olsalazine Disodium-13C12 | Olsalazine disodium-13C12 is the 13C-labeled Olsalazine disodium (HY-B0174). Olsalazine Disodium is an anti-inflammatory compound that works in inflammatory bowel disease and ulcerative colitis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.83
HY-B0174AROlsalazine (Standard) -
Similarity Score 0.80
HY-D0439C.I. Mordant yellow 12 -
Similarity Score 0.78
HY-D0235Alizarin yellow GG -
Similarity Score 0.78
HY-D0258Alizarin Yellow R sodium -
Similarity Score 0.72
HY-118320Alizarine Yellow R -
Similarity Score 0.72
HY-108127NAA-004 -
Similarity Score 0.71
HY-136480Chrysamine G -
Similarity Score 0.69
HY-W1129034,4′-(1,2-Diazenediyl)bis[2-methylbenzoic acid] -
Similarity Score 0.69
HY-108244Balsalazide disodium -
Explore the MedChemAI to find more analogs
References
- [1]. Brown WA, et al. 5-aminosalicyclic acid and olsalazine inhibit tumor growth in a rodent model of colorectal cancer. Dig Dis Sci. 2000 Aug;45(8):1578-84. [Content Brief]
- [2]. Thapa D, et al. Cannabidiol Enhances the Therapeutic Efficacy of Olsalazine and Cyclosporine in a Murine Model of Colitis. Int J Mol Sci. 2025 Aug 16;26(16):7913. [Content Brief]
- [3]. Niu Y, et al. Olsalazine Sodium Increases Renal Urate Excretion by Modulating Urate Transporters in Hyperuricemic Animals. Biol Pharm Bull. 2020 Nov 1;43(11):1653-1659. [Content Brief]
- [4]. Itoh S, et al. Olsalazine inhibits cell proliferation and DNA methylation in canine lymphoid tumor cell lines. Pol J Vet Sci. 2021 Dec;24(4):515-523. [Content Brief]